Contact and place of performance
Jessica Kiser
Not specified
NOTICE OF INTENT TO AWARD A SOLE SOURCE: Department of Veterans Affairs (VA), Network Contracting Office (NCO) 8, Orlando VA Healthcare System intends to solicit and award a sole source Blanket Purchase Agreement against Federal Schedule Contract 36F79719D0170 to Progenics Pharmaceuticals, 331 Treble Cove Road, N. Billerica, MA 01862 to provide Pylarify-Piflufolastat F 18 Injection for the Nuclear Medicine Department...
View moreThe Department of Veterans Affairs, Network Contracting Office (NCO) 8, intends to establish a sole source Blanket Purchase Agreement with Progenics Pharmaceuticals for the procurement of Pylarify-Piflufolastat F 18 Injection. This medication is required for the Nuclear Medicine Department at the Orlando VA Healthcare System. The procurement is being conducted against Federal Schedule Contract 36F79719D0170 under the authority of FAR 8.405-6(b). The anticipated period of performance consists of a one-year base period followed by four twelve-month option periods.
This special notice, identified by solicitation number 36C24823Q0666, is categorized under NAICS code 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and BiologicalS). This is not a request for competitive quotes, and the government does not intend to release a formal solicitation. Two documents are attached to the notice: a redacted Limited Sources Justification and a secondary Word document.
The response deadline for vendors to submit technical capability statements for consideration in future procurements is March 10, 2023, at 12:00 PM EST. Jessica Kiser is the designated point of contact for this requirement. Submissions will be used solely to determine potential sources for subsequent needs, and the government will not provide reimbursement for any information received.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.